3VFB | Hydrolase Hydrolase Inhibitor | date | Jan 09, 2012 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Hiv-1 Protease Mutant N88d With Novel P Grl-02031 | ||||||||||||||
authors | X.X.Yu, Y.F.Wang, Y.C.E.Chang, I.T.Weber | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Protease Chain: A, B Fragment: Unp Residues 501-599 Ec: 3.4.23.16 Engineered: Yes Mutation: Yes |
Organism_scientific: Human Immunodeficiency Virus Type 1 (B Isolate); Organism_common: Hiv-1 Organism_taxid: 11686 Gene: Gag-Pol Expression_system: Escherichia Coli Expression_system_taxid: 469008 Expression_system_strain: Bl21 (De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet11a | ||||||||||||||
symmetry | Space Group: P 21 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.55 Å | ||||||||||||
ligand | 031, CL, GOL, NA | enzyme | Hydrolase E.C.3.4.23.16 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring., Chang YC, Yu X, Zhang Y, Tie Y, Wang YF, Yashchuk S, Ghosh AK, Harrison RW, Weber IT, J Med Chem. 2012 Apr 12;55(7):3387-97. doi: 10.1021/jm300072d. Epub 2012 Mar 22. PMID:22401672 |
Data retrieval |
View 3VFB in 3D |
Visual 3D analysis of 3VFB |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3VFB |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |